Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.22.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Apr. 30, 2022
Jul. 31, 2021
Current assets:    
Cash and cash equivalents $ 31,130 $ 13,524
Marketable securities   29,978
Accounts receivable, net 11,761 10,198
Inventories 14,934 12,652
Prepaid expenses 4,474 4,230
Total current assets 62,299 70,582
Property, plant, and equipment, net 17,545 16,585
Right-of-use assets 14,962 17,020
Goodwill 7,452 7,452
Intangible assets, net 29 244
Other, including restricted cash of $1,000 at April 30, 2022 and $750 at July 31, 2021 1,617 1,808
Total assets 103,904 113,691
Current liabilities:    
Accounts payable – trade 7,664 8,123
Accrued liabilities 13,629 14,301
Current portion of operating lease liabilities 3,171 3,419
Other current liabilities and finance leases short term 238 233
Total current liabilities 24,702 26,076
Finance leases long term and other liabilities 59 115
Operating lease liabilities, non-current 12,779 14,558
Long term debt – net 4,177 4,356
Total liabilities 41,717 45,105
Commitments and contingencies – see Note 12
Stockholders’ equity:    
Preferred Stock, $.01 par value; authorized 25,000,000 shares; no shares issued or outstanding
Common Stock, $.01 par value; authorized 75,000,000 shares; shares issued and outstanding: 48,720,454 at April 30, 2022 and 48,471,771 at July 31, 2021 487 485
Additional paid-in capital 339,023 337,126
Accumulated deficit (280,205) (270,377)
Accumulated other comprehensive income 2,882 1,352
Total stockholders’ equity 62,187 68,586
Total liabilities and stockholders’ equity $ 103,904 $ 113,691